Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Bora has announced the opening of its first North American office in Delaware, U.S.
read more
Taiwan-based contract development and manufacturing organization (CDMO) Bora Pharmaceuticals has announced the establishment of Bora Biologics Co., Ltd., a CDMO platform for biologics.
read more
Wednesday, December 02, 2020
Bora Pharmaceuticals announced the CDMO has successfully completed the acquisition of GSK’s Mississauga, Ontario facility.
read more
Thursday, September 22, 2022
Bora Pharmaceutical Labs, a division of Bora Pharmaceuticals, partnered with TaiRx, a Taiwanese drug development company, to manufacture a novel anticancer drug, CVM-1118.
read more
Bora Pharmaceuticals and GSK have entered into an agreement under which Bora Pharmaceuticals will acquire GSK's Mississauga, Ontario (Canada) facility.
read more
Tuesday, September 03, 2019
Bora has reported a successful FDA general inspection for its facility in Zhunan, Taiwan.
read more
Saturday, September 25, 2021
Clinical logistics and life science manufacturing leaders Boston Labs and Germfree Laboratories Inc. today announced their partnership to launch a new network of mobile CGT manufacturing facilities. The two companies are combining deep logistics, CGT...
read more
Wednesday, November 08, 2017
Bracket announced the addition of Christopher Crucitti, Chief Commercial Officer to its global executive team.
read more
Friday, February 12, 2021
BrainStorm recently concluded a Type C meeting with the FDA to review aspects of the company's planned manufacturing modifications to support the development of a semi-automated commercial manufacturing process for NurOwn.
read more
BrainStorm Cell Therapeutics has contracted with the Connell and O'Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute as a second U.S. manufacturing site to supply NurOwn.
read more
Tuesday, December 07, 2021
BrainStorm Cell Therapeutics Inc., a developer of cellular therapies for neurodegenerative diseases, and Catalent, a provider of services enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of ...
read more
Wednesday, January 03, 2018
BrainStorm Cell Therapeutics has received GMP approval from the Israel Ministry of Health for its Israeli contract manufacturing facility.
read more
Monday, September 18, 2017
Brammer Bio announced completion of its clinical capacity expansion in Alachua, Florida.
read more
Monday, November 27, 2017
Brammer Bio announced the completion of renovations and launch of its late-stage clinical capacity and commercial-ready cGMP manufacturing site in Cambridge, Massachusetts for gene therapy products.
read more
Friday, February 27, 2015
Brazil, a signature country of South America just surpassed 200 million residents. It is the main economy in Latin America and one of the most important at world level, regionally considered industrialized in spite of the variety of income, from very...
read more